Naloxone formulation for overdose reversal preference among patients receiving opioids for pain management.
CONCLUSIONS: Two independent cohorts of respondents who were receiving opioid medications for pain management reported a preference for noninjectable over injectable formulations of naloxone to reverse an opioid overdose. Though initial preference is only one of many factors that impacts ultimate public acceptance and uptake of a new product, these results support the additional research and development of noninjectable naloxone formulations.
PMID: 29625751 [PubMed - as supplied by publisher]
Source: Addictive Behaviors - Category: Addiction Authors: Dunn KE, Barrett FS, Bigelow GE Tags: Addict Behav Source Type: research
More News: Addiction | Overdose | Pain | Pain Management | Training | Universities & Medical Training